Sumitomo Pharma Co., Ltd
Global Value, Access and Commercialization Director – Regenerative Medicines
US-Remote · Director
Sponsorship not specified$196k-$246kDetected 15 days ago
AccessibilityStakeholder ManagementRecruitingCRISPRResearchLeadershipCommunicationProblem Solving
About the role
- With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner.
- For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn.
- Disclaimer: The above statements are intended to describe the general nature and level of work being performed by people assigned to this classification.
Responsibilities
- Achieve and maintain Compliance with all applicable regulatory, legal and operational rules and procedures, by ensuring that all plans and activities for and on behalf of Sumitomo Pharma America (SMPA) and affiliates are carried out with the "best" industry practices and the highest ethical standards.
- Own and drive day-to-day execution of OUS market access priorities across assets, ensuring alignment to central strategy, timelines, and long-range plans.
Requirements
- Must be able to exercise appropriate judgment as necessary.
- Excellent written and oral communication skills required.
- Requires ability to use a personal computer for extended periods of time.
- Must be able to travel domestically and internationally as needed.
- Applicants for sales/field, manufacturing, or other designated roles will be required to submit to a pre-employment drug test.
- Bachelor's degree required; advanced degree preferred (e.g., MBA, MPH, PharmD, PhD, MS, or equivalent)
- Comfort operating in a dynamic, ambiguous environment where access strategy must be developed in parallel with evolving clinical and regulatory plans
- Must be comfortable spending 30% of time traveling; some overnight travel required
- Bachelor's degree required
- advanced degree preferred (e.g., MBA, MPH, PharmD, PhD, MS, or equivalent)
- 10+ years of progressive business experience in the healthcare, pharma or biotech industry, inclusive of global market access, pricing & reimbursement, value strategy, HEOR interface, or global commercial strategy
- experience in cell, gene, and regenerative medicines a plus
- Experience with EU markets and country-level HTAs, pricing and reimbursement
- JCA experience preferred
- Strong understanding of payer, reimbursement, HTA, and access dynamics in OUS settings
- Ability to synthesize clinical, economic, operational, and policy information into clear strategic recommendations
- Excellent communication, executive presence, and stakeholder management skills
- Experience in rare disease, specialty therapeutics, biologics, cell therapy, gene therapy, tissue-based therapies, or other advanced modalities highly preferred
Compensation
- The base salary range for this role is
Benefits
- Lead development and execution of OUS market access, pricing, and reimbursement strategies across priority OUS markets, aligned with centrally defined global strategy
- Drive OUS launch readiness activities related to access pathways, reimbursement planning, and pricing implementation
- Identify market-specific access risks, reimbursement barriers, policy constraints, and operational dependencies that may impact OUS launch readiness or uptake
- Lead HTA planning and execution across priority markets, including EU JCA and relevant country-level reimbursement pathways
- Develop country-level pricing and reimbursement recommendations aligned with centrally defined pricing guardrails
- Support pricing and reimbursement negotiations in partnership with regional stakeholders, affiliates, and external partners as applicable
- Monitor international pricing, reimbursement, and policy developments-including reference pricing and analogous cross-market risks-and recommend mitigation strategies
- Accountable for OUS access outcomes, including HTA success, reimbursement readiness, pricing alignment, and time to market access
- Experience with EU markets and country-level HTAs, pricing and reimbursement; JCA experience preferred
Equal opportunity
- Sumitomo Pharma America (SMPA) is an Equal Employment Opportunity (EEO) employer
- This contact information is for accommodation requests only and cannot be used to inquire about the status of applications.
Apply directly at Sumitomo Pharma Co., Ltd →Create a free account for alerts like thisView Sumitomo Pharma Co., Ltd immigration profile
This listing is sourced directly from Sumitomo Pharma Co., Ltd's careers page and normalized into a canonical job model.